{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:15:14Z","timestamp":1789827314796,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM104357-02"],"award-info":[{"award-number":["P20GM104357-02"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1T32HL105324"],"award-info":[{"award-number":["1T32HL105324"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["PO1HL-051971"],"award-info":[{"award-number":["PO1HL-051971"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K01HL-125445"],"award-info":[{"award-number":["K01HL-125445"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.abb.2019.108072","type":"journal-article","created":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T09:57:55Z","timestamp":1565863075000},"page":"108072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation"],"prefix":"10.1016","volume":"672","author":[{"given":"Darren M.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel O.","family":"Adeosun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somtochukwu I.","family":"Ngwudike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Terry D.","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Stec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.abb.2019.108072_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: the third national Health and nutrition examination survey, 1988-1994","volume":"178","author":"Lazo","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.abb.2019.108072_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.abb.2019.108072_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1665-2681(19)30879-8","article-title":"The prevalence of nonalcoholic fatty liver disease in the Americas","volume":"13","author":"Lopez-Velazquez","year":"2014","journal-title":"Ann. Hepatol."},{"issue":"3","key":"10.1016\/j.abb.2019.108072_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/10408363.2011.596521","article-title":"Non-alcoholic fatty liver disease","volume":"48","author":"Smith","year":"2011","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"50","key":"10.1016\/j.abb.2019.108072_bib5","doi-asserted-by":"crossref","first-page":"25776","DOI":"10.1074\/jbc.M116.752311","article-title":"Glucocorticoid receptor beta induces hepatic steatosis by augmenting inflammation and inhibition of the peroxisome proliferator-activated receptor (PPAR) alpha","volume":"291","author":"Marino","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"4792","key":"10.1016\/j.abb.2019.108072_bib6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.abb.2019.108072_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10715768909073428","article-title":"Antioxidant properties of conjugated bilirubin and biliverdin: biologically relevant scavenging of hypochlorous acid","volume":"6","author":"Stocker","year":"1989","journal-title":"Free Radic. Res. Commun."},{"issue":"13","key":"10.1016\/j.abb.2019.108072_bib8","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1096\/fj.04-2368fje","article-title":"Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats","volume":"19","author":"Lanone","year":"2005","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.abb.2019.108072_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.trre.2018.06.003","article-title":"Bilirubin, a new therapeutic for kidney transplant?","volume":"32","author":"Sundararaghavan","year":"2018","journal-title":"Transplant. Rev."},{"issue":"4","key":"10.1016\/j.abb.2019.108072_bib10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/HYPERTENSIONAHA.118.11130","article-title":"Bilirubin, a cardiometabolic signaling molecule","volume":"72","author":"Hinds","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.abb.2019.108072_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fcell.2016.00080","article-title":"Therapeutic efficacy of stem cells transplantation in diabetes: role of heme oxygenase","volume":"4","author":"Raffaele","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.abb.2019.108072_bib13","doi-asserted-by":"crossref","first-page":"G668","DOI":"10.1152\/ajpgi.00026.2018","article-title":"Biliverdin reductase and bilirubin in hepatic disease","volume":"314","author":"Weaver","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.abb.2019.108072_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tem.2018.01.002","article-title":"Bilirubin in the liver-gut signaling Axis","volume":"29","author":"Hamoud","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.abb.2019.108072_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yexcr.2019.04.029","article-title":"Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1alpha-HO-1-PGC1alpha-mitochondrial signaling","volume":"380","author":"Raffaele","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.abb.2019.108072_bib16","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1542\/peds.2008-3087","article-title":"Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease","volume":"124","author":"Lin","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.abb.2019.108072_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MPG.0b013e318291fefe","article-title":"Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children","volume":"57","author":"Puri","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"4","key":"10.1016\/j.abb.2019.108072_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3350\/cmh.2012.18.4.357","article-title":"Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease","volume":"18","author":"Jang","year":"2012","journal-title":"Clin. Mol. Hepatol."},{"issue":"3","key":"10.1016\/j.abb.2019.108072_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.clinbiochem.2011.11.017","article-title":"Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response","volume":"45","author":"Kumar","year":"2012","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.abb.2019.108072_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3350\/cmh.2012.18.4.383","article-title":"Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease","volume":"18","author":"Kwak","year":"2012","journal-title":"Clin. Mol. Hepatol."},{"issue":"4","key":"10.1016\/j.abb.2019.108072_bib21","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1152\/ajpendo.00396.2016","article-title":"Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARalpha","volume":"312","author":"Hinds","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.abb.2019.108072_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tem.2015.02.001","article-title":"Biliverdin reductase isozymes in metabolism","volume":"26","author":"O'Brien","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.abb.2019.108072_bib23","doi-asserted-by":"crossref","first-page":"F323","DOI":"10.1152\/ajprenal.00495.2017","article-title":"Loss of biliverdin reductase-A promotes lipid accumulation and lipotoxicity in mouse proximal tubule cells","volume":"315","author":"Adeosun","year":"2018","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"2","key":"10.1016\/j.abb.2019.108072_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.yjmcc.2010.04.011","article-title":"Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin","volume":"49","author":"Jansen","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.abb.2019.108072_bib25","doi-asserted-by":"crossref","first-page":"R1546","DOI":"10.1152\/ajpregu.90933.2008","article-title":"Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells","volume":"297","author":"Young","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.abb.2019.108072_bib26","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bbadis.2019.02.021","article-title":"Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity","volume":"1865","author":"Cimini","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"13","key":"10.1016\/j.abb.2019.108072_bib27","first-page":"35","article-title":"A novel fluorescence-based assay for the measurement of biliverdin reductase activity","volume":"5","author":"Adeosun","year":"2018","journal-title":"React. Oxyg. Species(Apex)"},{"key":"10.1016\/j.abb.2019.108072_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.exer.2015.05.023","article-title":"Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes","volume":"138","author":"Kaja","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.abb.2019.108072_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jep.2018.06.003","article-title":"Protective effects of flavonoids from Coreopsis tinctoria Nutt. on experimental acute pancreatitis via Nrf-2\/ARE-mediated antioxidant pathways","volume":"224","author":"Du","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.abb.2019.108072_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10616-011-9423-0","article-title":"A rapid fluorescent screening method for cellular sensitivity to anti-cancer compound","volume":"64","author":"Mao","year":"2012","journal-title":"Cytotechnology"},{"issue":"1","key":"10.1016\/j.abb.2019.108072_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-5793(97)01159-9","article-title":"High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria","volume":"416","author":"Korshunov","year":"1997","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.abb.2019.108072_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-7075-9-94","article-title":"Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress","volume":"9","author":"Yang","year":"2012","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.abb.2019.108072_bib33","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3389\/fphys.2018.01180","article-title":"The diurnal timing of starvation differently impacts murine hepatic gene expression and lipid metabolism - a systems biology analysis using self-organizing maps","volume":"9","author":"Rennert","year":"2018","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.abb.2019.108072_bib34","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/ars.2013.5486","article-title":"Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver","volume":"21","author":"Reiniers","year":"2014","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.abb.2019.108072_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis","volume":"52","author":"Rolo","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.abb.2019.108072_bib36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/oby.20559","article-title":"Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21","volume":"22","author":"Hinds","year":"2014","journal-title":"Obesity"},{"issue":"48","key":"10.1016\/j.abb.2019.108072_bib37","doi-asserted-by":"crossref","first-page":"25179","DOI":"10.1074\/jbc.M116.731703","article-title":"Biliverdin reductase a attenuates hepatic steatosis by inhibition of glycogen synthase kinase (GSK) 3beta phosphorylation of serine 73 of peroxisome proliferator-activated receptor (PPAR) alpha","volume":"291","author":"Hinds","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.abb.2019.108072_bib39","doi-asserted-by":"crossref","first-page":"e0153427","DOI":"10.1371\/journal.pone.0153427","article-title":"Bilirubin binding to PPARalpha inhibits lipid accumulation","volume":"11","author":"Stec","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.abb.2019.108072_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1152\/physiolgenomics.00028.2019","article-title":"RNA sequencing in human HepG2 hepatocytes reveals PPAR-\u03b1 mediates transcriptome responsiveness of bilirubin","volume":"51","author":"Gordon","year":"2019","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.abb.2019.108072_bib41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.freeradbiomed.2017.11.020","article-title":"Absence of the biliverdin reductase-a gene is associated with increased endogenous oxidative stress","volume":"115","author":"Chen","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"43","key":"10.1016\/j.abb.2019.108072_bib42","doi-asserted-by":"crossref","first-page":"29251","DOI":"10.1074\/jbc.M109.037119","article-title":"Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase","volume":"284","author":"Maghzal","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2019.108072_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2018.07.004","article-title":"Ablation of soluble epoxide hydrolase reprogram white fat to beige-like fat through an increase in mitochondrial integrity, HO-1-adiponectin in vitro and in vivo","volume":"138","author":"Liu","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.abb.2019.108072_bib44","article-title":"Ablation of adipose-HO-1 expression increases white fat over beige fat through inhibition of mitochondrial fusion and of PGC1alpha in female mice","volume":"31","author":"Singh","year":"2017","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.abb.2019.108072_bib45","doi-asserted-by":"crossref","first-page":"5310961","DOI":"10.1155\/2018\/5310961","article-title":"N-acetylcysteine (NAC) ameliorates lipid-related metabolic dysfunction in bone marrow stromal cells-derived adipocytes","volume":"2018","author":"Raffaele","year":"2018","journal-title":"Evid. Based Complement Altern. Med."},{"issue":"8","key":"10.1016\/j.abb.2019.108072_bib46","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1096\/fj.05-4204fje","article-title":"HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism","volume":"20","author":"Converso","year":"2006","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.abb.2019.108072_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.taap.2014.11.010","article-title":"Mitochondrial targeting of bilirubin regulatory enzymes: an adaptive response to oxidative stress","volume":"282","author":"Muhsain","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.abb.2019.108072_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0168-8278(01)00279-3","article-title":"Bilirubin directly disrupts membrane lipid polarity and fluidity, protein order, and redox status in rat mitochondria","volume":"36","author":"Rodrigues","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.abb.2019.108072_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-1-4939-7831-1_22","article-title":"Relation between mitochondrial membrane potential and ROS formation","volume":"1782","author":"Suski","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.abb.2019.108072_bib50","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1096\/fj.201600330RR","article-title":"Interaction of human biliverdin reductase with Akt\/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation","volume":"30","author":"Miralem","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.abb.2019.108072_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nbd.2019.02.003","article-title":"Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease","volume":"125","author":"Sharma","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.abb.2019.108072_bib52","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.bbadis.2018.07.005","article-title":"Biliverdin reductase-A impairment links brain insulin resistance with increased Abeta production in an animal model of aging: implications for Alzheimer disease","volume":"1864","author":"Triani","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.abb.2019.108072_bib53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.freeradbiomed.2015.12.012","article-title":"Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: a new paradigm","volume":"91","author":"Barone","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.abb.2019.108072_bib54","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1007\/s12035-018-1231-5","article-title":"Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in alzheimer disease","volume":"56","author":"Barone","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.abb.2019.108072_bib55","doi-asserted-by":"crossref","first-page":"4712053","DOI":"10.1155\/2016\/4712053","article-title":"Nanoparticle delivered human biliverdin reductase-based peptide increases glucose uptake by activating IRK\/Akt\/GSK3 Axis: the peptide is effective in the cell and wild-type and diabetic ob\/ob mice","volume":"2016","author":"Gibbs","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"6","key":"10.1016\/j.abb.2019.108072_bib56","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1096\/fj.13-247015","article-title":"Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor","volume":"28","author":"Gibbs","year":"2014","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.abb.2019.108072_bib57","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.2174\/1389450111009011586","article-title":"Potential application of biliverdin reductase and its fragments to modulate insulin\/IGF-1\/MAPK\/PI3-K signaling pathways in therapeutic settings","volume":"11","author":"Maines","year":"2010","journal-title":"Curr. Drug Targets"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986119302097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986119302097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:16:34Z","timestamp":1777389394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986119302097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":55,"alternative-id":["S0003986119302097"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2019.108072","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2019.108072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108072"}}